메뉴 건너뛰기




Volumn 36, Issue 1, 2010, Pages 41-48

Disorders of coagulation and hemostasis in abdominal obesity: Emerging role of fatty liver

Author keywords

Abdominal obesity; Blood coagulation disorders; Hemostatic factors; Inflammation; Insulin resistance; Nonalcoholic fatty liver disease

Indexed keywords

ABDOMINAL OBESITY; ATHEROSCLEROSIS; BLOOD CLOTTING DISORDER; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; EPIDEMIC; FIBRINOLYSIS; HEMOSTASIS; HUMAN; NONALCOHOLIC FATTY LIVER; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; THROMBOSIS;

EID: 77951063159     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0030-1248723     Document Type: Review
Times cited : (52)

References (67)
  • 3
    • 41649097735 scopus 로고    scopus 로고
    • Abdominal obesity and the risk of all-cause, cardiovascular, and cancer mortality: Sixteen years of follow-up in US women
    • Zhang C, Rexrode K M., van Dam R M., Li T Y., Hu F B. Abdominal obesity and the risk of all-cause, cardiovascular, and cancer mortality: sixteen years of follow-up in US women. Circulation 2008 117 (13) 1658-1667
    • (2008) Circulation , vol.117 , Issue.13 , pp. 1658-1667
    • Zhang, C.1    Rexrode, K.M.2    Van Dam, R.M.3    Li, T.Y.4    Hu, F.B.5
  • 4
    • 56249131806 scopus 로고    scopus 로고
    • General and abdominal adiposity and risk of death in Europe
    • Pischon T, Boeing H, Hoffmann K et al. General and abdominal adiposity and risk of death in Europe. N Engl J Med 2008 359 (20) 2105-2120
    • (2008) N Engl J Med , vol.359 , Issue.20 , pp. 2105-2120
    • Pischon, T.1    Boeing, H.2    Hoffmann, K.3
  • 5
    • 0028917432 scopus 로고
    • Weight gain as a risk factor for clinical diabetes mellitus in women
    • Colditz G A., Willett W C., Rotnitzky A, Manson J E. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med 1995 122 (7) 481-486
    • (1995) Ann Intern Med , vol.122 , Issue.7 , pp. 481-486
    • Colditz, G.A.1    Willett, W.C.2    Rotnitzky, A.3    Manson, J.E.4
  • 7
    • 37549047145 scopus 로고    scopus 로고
    • Fatty liver: A novel component of the metabolic syndrome
    • Kotronen A, Yki-Jrvinen H. Fatty liver: a novel component of the metabolic syndrome. Arterioscler Thromb Vasc Biol 2008 28 (1) 27-38
    • (2008) Arterioscler Thromb Vasc Biol , vol.28 , Issue.1 , pp. 27-38
    • Kotronen, A.1    Yki-Jrvinen, H.2
  • 8
    • 33845914986 scopus 로고    scopus 로고
    • Mechanisms linking obesity with cardiovascular disease
    • DOI 10.1038/nature05487, PII NATURE05487
    • Van Gaal L F., Mertens I L., De Block C E. Mechanisms linking obesity with cardiovascular disease. Nature 2006 444 (7121) 875-880 (Pubitemid 46028447)
    • (2006) Nature , vol.444 , Issue.7121 , pp. 875-880
    • Van Gaal, L.F.1    Mertens, I.L.2    De Block, C.E.3
  • 9
    • 19344371077 scopus 로고    scopus 로고
    • Visceral fat as a determinant of fibrinolysis and hemostasis
    • DOI 10.1055/s-2005-871741
    • Mertens I, Van Gaal L F. Visceral fat as a determinant of fibrinolysis and hemostasis. Semin Vasc Med 2005 5 (1) 48-55 (Pubitemid 40721045)
    • (2005) Seminars in Vascular Medicine , vol.5 , Issue.1 , pp. 48-55
    • Mertens, I.1    Van Gaal, L.F.2
  • 10
    • 44849093847 scopus 로고    scopus 로고
    • Abdominal obesity and the metabolic syndrome: Contribution to global cardiometabolic risk
    • Desprs J P., Lemieux I, Bergeron J et al. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol 2008 28 (6) 1039-1049
    • (2008) Arterioscler Thromb Vasc Biol , vol.28 , Issue.6 , pp. 1039-1049
    • Desprs, J.P.1    Lemieux, I.2    Bergeron, J.3
  • 11
    • 38549101510 scopus 로고    scopus 로고
    • Hemostatic dysfunction associated with endocrine disorders as a major risk factor and cause of human morbidity and mortality: A comprehensive meta-review
    • DOI 10.1055/s-2007-1000372
    • Mina A, Favaloro E J., Koutts J. Hemostatic dysfunction associated with endocrine disorders as a major risk factor and cause of human morbidity and mortality: a comprehensive meta-review. Semin Thromb Hemost 2007 33 (8) 798-809 (Pubitemid 351158448)
    • (2007) Seminars in Thrombosis and Hemostasis , vol.33 , Issue.8 , pp. 798-809
    • Mina, A.1    Favaloro, E.J.2    Koutts, J.3
  • 12
    • 44949088433 scopus 로고    scopus 로고
    • Metabolic syndrome, haemostasis and thrombosis
    • DOI 10.1160/TH07-11-0682
    • Alessi M C., Juhan-Vague I. Metabolic syndrome, haemostasis and thrombosis. Thromb Haemost 2008 99 (6) 995-1000 (Pubitemid 351810479)
    • (2008) Thrombosis and Haemostasis , vol.99 , Issue.6 , pp. 995-1000
    • Alessi, M.-C.1    Juhan-Vague, I.2
  • 13
    • 70449442756 scopus 로고    scopus 로고
    • The metabolic syndrome as a risk factor for venous and arterial thrombosis
    • Dentali F, Squizzato A, Ageno W. The metabolic syndrome as a risk factor for venous and arterial thrombosis. Semin Thromb Hemost 2009 35 (5) 451-457
    • (2009) Semin Thromb Hemost , vol.35 , Issue.5 , pp. 451-457
    • Dentali, F.1    Squizzato, A.2    Ageno, W.3
  • 14
    • 52149093835 scopus 로고    scopus 로고
    • The metabolic syndrome and the risk of arterial and venous thrombosis
    • Franchini M, Targher G, Montagnana M, Lippi G. The metabolic syndrome and the risk of arterial and venous thrombosis. Thromb Res 2008 122 (6) 727-735
    • (2008) Thromb Res , vol.122 , Issue.6 , pp. 727-735
    • Franchini, M.1    Targher, G.2    Montagnana, M.3    Lippi, G.4
  • 15
    • 34248571463 scopus 로고    scopus 로고
    • Mean platelet volume in patients with metabolic syndrome and its relationship with coronary artery disease
    • DOI 10.1016/j.thromres.2006.10.005, PII S0049384806003926
    • Tavil Y, Sen N, Yazici H U., Hizal F, Abaci A, Cengel A. Mean platelet volume in patients with metabolic syndrome and its relationship with coronary artery disease. Thromb Res 2007 120 (2) 245-250 (Pubitemid 46759554)
    • (2007) Thrombosis Research , vol.120 , Issue.2 , pp. 245-250
    • Tavil, Y.1    Sen, N.2    Yazici, H.U.3    Hizal, F.4    Abaci, A.5    Cengel, A.6
  • 18
    • 43849092981 scopus 로고    scopus 로고
    • Platelet counts and platelet activation markers in obese subjects
    • ID 834153
    • Samocha-Bonet D, Justo D, Rogowski O et al. Platelet counts and platelet activation markers in obese subjects. Mediators Inflamm 2008 2008 ID 834153
    • (2008) Mediators Inflamm , vol.2008
    • Samocha-Bonet, D.1    Justo, D.2    Rogowski, O.3
  • 20
    • 40549099344 scopus 로고    scopus 로고
    • Effects of weight loss from a very-low-carbohydrate diet on endothelial function and markers of cardiovascular disease risk in subjects with abdominal obesity
    • Keogh J B., Brinkworth G D., Noakes M, Belobrajdic D P., Buckley J D., Clifton P M. Effects of weight loss from a very-low-carbohydrate diet on endothelial function and markers of cardiovascular disease risk in subjects with abdominal obesity. Am J Clin Nutr 2008 87 (3) 567-576 (Pubitemid 351364536)
    • (2008) American Journal of Clinical Nutrition , vol.87 , Issue.3 , pp. 567-576
    • Keogh, J.B.1    Brinkworth, G.D.2    Noakes, M.3    Belobrajdic, D.P.4    Buckley, J.D.5    Clifton, P.M.6
  • 21
    • 30744470141 scopus 로고    scopus 로고
    • Soluble P-selectin and CD40L levels in subjects with prediabetes, diabetes mellitus, and metabolic syndrome - The Chennai Urban Rural Epidemiology Study
    • DOI 10.1016/j.metabol.2005.08.019, PII S0026049505003410
    • Gokulakrishnan K, Deepa R, Mohan V, Gross M D. Soluble P-selectin and CD40L levels in subjects with prediabetes, diabetes mellitus, and metabolic syndromethe Chennai Urban Rural Epidemiology Study. Metabolism 2006 55 (2) 237-242 (Pubitemid 43098993)
    • (2006) Metabolism: Clinical and Experimental , vol.55 , Issue.2 , pp. 237-242
    • Gokulakrishnan, K.1    Deepa, R.2    Mohan, V.3    Gross, M.D.4
  • 22
    • 33745727432 scopus 로고    scopus 로고
    • The presence of metabolic syndrome is independently associated with elevated serum CD40 ligand and disease severity in patients with symptomatic coronary artery disease
    • Lee W L., Lee W J., Chen Y T. et al. The presence of metabolic syndrome is independently associated with elevated serum CD40 ligand and disease severity in patients with symptomatic coronary artery disease. Metabolism 2006 55 (8) 1029-1034
    • (2006) Metabolism , vol.55 , Issue.8 , pp. 1029-1034
    • Lee, W.L.1    Lee, W.J.2    Chen, Y.T.3
  • 23
    • 33646496156 scopus 로고    scopus 로고
    • Enhanced soluble CD40L in patients with the metabolic syndrome: Relationship with in vivo thrombin generation
    • Angelico F, Alessandri C, Ferro D et al. Enhanced soluble CD40L in patients with the metabolic syndrome: relationship with in vivo thrombin generation. Diabetologia 2006 49 (6) 1169-1174
    • (2006) Diabetologia , vol.49 , Issue.6 , pp. 1169-1174
    • Angelico, F.1    Alessandri, C.2    Ferro, D.3
  • 24
    • 45149117343 scopus 로고    scopus 로고
    • The proinflammatory mediator CD40 ligand is increased in the metabolic syndrome and modulated by adiponectin
    • DOI 10.1210/jc.2007-2491
    • Natal C, Restituto P, Iigo C, Colina I, Dez J, Varo N. The proinflammatory mediator CD40 ligand is increased in the metabolic syndrome and modulated by adiponectin. J Clin Endocrinol Metab 2008 93 (6) 2319-2327 (Pubitemid 351831554)
    • (2008) Journal of Clinical Endocrinology and Metabolism , vol.93 , Issue.6 , pp. 2319-2327
    • Natal, C.1    Restituto, P.2    Inigo, C.3    Colina, I.4    Diez, J.5    Varo, N.6
  • 25
    • 77951088791 scopus 로고    scopus 로고
    • In central obesity, weight loss restores platelet sensitivity to nitric oxide and prostacyclin
    • October 15 (Epub ahead of print)
    • Russo I, Traversa M, Bonomo K et al. In central obesity, weight loss restores platelet sensitivity to nitric oxide and prostacyclin. Obesity (Silver Spring) 2009 October 15 (Epub ahead of print)
    • (2009) Obesity (Silver Spring)
    • Russo, I.1    Traversa, M.2    Bonomo, K.3
  • 26
    • 33750842744 scopus 로고    scopus 로고
    • Impact of weight reduction on production of platelet-derived microparticles and fibrinolytic parameters in obesity
    • DOI 10.1016/j.thromres.2005.12.013, PII S0049384805004949
    • Murakami T, Horigome H, Tanaka K et al. Impact of weight reduction on production of platelet-derived microparticles and fibrinolytic parameters in obesity. Thromb Res 2007 119 (1) 45-53 (Pubitemid 44716205)
    • (2007) Thrombosis Research , vol.119 , Issue.1 , pp. 45-53
    • Murakami, T.1    Horigome, H.2    Tanaka, K.3    Nakata, Y.4    Ohkawara, K.5    Katayama, Y.6    Matsui, A.7
  • 28
    • 33746633023 scopus 로고    scopus 로고
    • Effects of VLDL and remnant particles on platelets
    • DOI 10.1159/000093221
    • Olufadi R, Byrne C D. Effects of VLDL and remnant particles on platelets. Pathophysiol Haemost Thromb 2006 35 (34) 281-291 (Pubitemid 44155946)
    • (2006) Pathophysiology of Haemostasis and Thrombosis , vol.35 , Issue.3-4 , pp. 281-291
    • Olufadi, R.1    Byrne, C.D.2
  • 32
    • 29244436339 scopus 로고    scopus 로고
    • Inverse relationship between plasminogen activator inhibitor-I activity and adiponectin in overweight and obese women. Interrelationship with visceral adipose tissue, insulin resistance, HDL-chol and inflammation
    • Mertens I, Ballaux D, Funahashi T et al. Inverse relationship between plasminogen activator inhibitor-I activity and adiponectin in overweight and obese women. Interrelationship with visceral adipose tissue, insulin resistance, HDL-chol and inflammation. Thromb Haemost 2005 94 (6) 1190-1195
    • (2005) Thromb Haemost , vol.94 , Issue.6 , pp. 1190-1195
    • Mertens, I.1    Ballaux, D.2    Funahashi, T.3
  • 33
    • 25844445415 scopus 로고    scopus 로고
    • Non-alcoholic hepatic steatosis and its relation to increased plasma biomarkers of inflammation and endothelial dysfunction in non-diabetic men. Role of visceral adipose tissue
    • DOI 10.1111/j.1464-5491.2005.01646.x
    • Targher G, Bertolini L, Scala L, Zoppini G, Zenari L, Falezza G. Non-alcoholic hepatic steatosis and its relation to increased plasma biomarkers of inflammation and endothelial dysfunction in non-diabetic men. Role of visceral adipose tissue. Diabet Med 2005 22 (10) 1354-1358 (Pubitemid 41391311)
    • (2005) Diabetic Medicine , vol.22 , Issue.10 , pp. 1354-1358
    • Targher, G.1    Bertolini, L.2    Scala, L.3    Zoppini, G.4    Zenari, L.5    Falezza, G.6
  • 34
    • 33646061982 scopus 로고    scopus 로고
    • Is visceral adipose tissue a determinant of von Willebrand factor in overweight and obese premenopausal women?
    • Mertens I, Van der Planken M, Corthouts B, Van Gaal L F. Is visceral adipose tissue a determinant of von Willebrand factor in overweight and obese premenopausal women? Metabolism 2006 55 (5) 650-655
    • (2006) Metabolism , vol.55 , Issue.5 , pp. 650-655
    • Mertens, I.1    Van Der Planken, M.2    Corthouts, B.3    Van Gaal, L.F.4
  • 37
    • 36348983866 scopus 로고    scopus 로고
    • Relationship of waist and hip circumference with coagulation and fibrinolysis in postmenopausal women
    • DOI 10.1042/CS20070084
    • Peverill R E., Teede H J., Malan E, Kotsopoulos D, Smolich J J., McGrath B P. Relationship of waist and hip circumference with coagulation and fibrinolysis in postmenopausal women. Clin Sci (Lond) 2007 113 (9) 383-391 (Pubitemid 350144370)
    • (2007) Clinical Science , vol.113 , Issue.9-10 , pp. 383-391
    • Peverill, R.E.1    Teede, H.J.2    Malan, E.3    Kotsopoulos, D.4    Smolich, J.J.5    McGrath, B.P.6
  • 38
    • 0042332075 scopus 로고    scopus 로고
    • Associations of haemostatic variables with body mass index: A community-based study
    • DOI 10.1097/00001721-200309000-00009
    • Bowles L K., Cooper J A., Howarth D J., Miller G J., MacCallum P K. Associations of haemostatic variables with body mass index: a community-based study. Blood Coagul Fibrinolysis 2003 14 (6) 569-573 (Pubitemid 37083173)
    • (2003) Blood Coagulation and Fibrinolysis , vol.14 , Issue.6 , pp. 569-573
    • Bowles, L.K.1    Cooper, J.A.2    Howarth, D.J.3    Miller, G.J.4    MacCallum, P.K.5
  • 40
    • 33748741980 scopus 로고    scopus 로고
    • Decrements in the thrombin activatable fibrinolysis inhibitor (TAFI) levels in association with orlistat treatment in obesity
    • Guven G S., Kiliaslan A, Oz S G. et al. Decrements in the thrombin activatable fibrinolysis inhibitor (TAFI) levels in association with orlistat treatment in obesity. Clin Appl Thromb Hemost 2006 12 (3) 364-368
    • (2006) Clin Appl Thromb Hemost , vol.12 , Issue.3 , pp. 364-368
    • Guven, G.S.1    Kiliaslan, A.2    Oz, S.G.3
  • 41
    • 0142137406 scopus 로고    scopus 로고
    • Weak and non-independent association between plasma TAFI antigen levels and the insulin resistance syndrome
    • Aubert H, Frre C, Aillaud M F., Morange P E., Juhan-Vague I, Alessi M C. Weak and non-independent association between plasma TAFI antigen levels and the insulin resistance syndrome. J Thromb Haemost 2003 1 (4) 791-797
    • (2003) J Thromb Haemost , vol.1 , Issue.4 , pp. 791-797
    • Aubert, H.1    Frre, C.2    Aillaud, M.F.3    Morange, P.E.4    Juhan-Vague, I.5    Alessi, M.C.6
  • 42
    • 0036123456 scopus 로고    scopus 로고
    • Factor XIII - Circulating levels and the Val34Leu polymorphism in the healthy male relatives of patients with severe coronary artery disease
    • Mills J D., Mansfield M W., Grant P J. Factor XIII-circulating levels and the Val34Leu polymorphism in the healthy male relatives of patients with severe coronary artery disease. Thromb Haemost 2002 87 (3) 409-414 (Pubitemid 34232480)
    • (2002) Thrombosis and Haemostasis , vol.87 , Issue.3 , pp. 409-414
    • Mills, J.D.1    Mansfield, M.W.2    Grant, P.J.3
  • 43
    • 0035512784 scopus 로고    scopus 로고
    • Relation between soluble adhesion molecules and insulin sensitivity in type 2 diabetic individuals: Role of adipose tissue
    • Targher G, Bonadonna R C., Alberiche M, Zenere M B., Muggeo M, Bonora E. Relation between soluble adhesion molecules and insulin sensitivity in type 2 diabetic individuals: role of adipose tissue. Diabetes Care 2001 24 (11) 1961-1966
    • (2001) Diabetes Care , vol.24 , Issue.11 , pp. 1961-1966
    • Targher, G.1    Bonadonna, R.C.2    Alberiche, M.3    Zenere, M.B.4    Muggeo, M.5    Bonora, E.6
  • 44
    • 33745168947 scopus 로고    scopus 로고
    • Endothelial microparticles and platelet and leukocyte activation in patients with the metabolic syndrome
    • Arteaga R B., Chirinos J A., Soriano A O. et al. Endothelial microparticles and platelet and leukocyte activation in patients with the metabolic syndrome. Am J Cardiol 2006 98 (1) 70-74
    • (2006) Am J Cardiol , vol.98 , Issue.1 , pp. 70-74
    • Arteaga, R.B.1    Chirinos, J.A.2    Soriano, A.O.3
  • 45
    • 0034966562 scopus 로고    scopus 로고
    • Plasma levels of free and total TFPI, relationship with cardiovascular risk factors and endothelial cell markers
    • Morange P E., Renucci J F., Charles M A. et al. Plasma levels of free and total TFPI, relationship with cardiovascular risk factors and endothelial cell markers. Thromb Haemost 2001 85 (6) 999-1003
    • (2001) Thromb Haemost , vol.85 , Issue.6 , pp. 999-1003
    • Morange, P.E.1    Renucci, J.F.2    Charles, M.A.3
  • 47
    • 60449115830 scopus 로고    scopus 로고
    • Activated protein C levels in obesity and weight loss influence
    • Solá E, Navarro S, Medina P et al. Activated protein C levels in obesity and weight loss influence. Thromb Res 2009 123 (5) 697-700
    • (2009) Thromb Res , vol.123 , Issue.5 , pp. 697-700
    • Solá, E.1    Navarro, S.2    Medina, P.3
  • 48
    • 40849083460 scopus 로고    scopus 로고
    • Non-alcoholic fatty liver disease: The mist gradually clears
    • de Alwis N M., Day C P. Non-alcoholic fatty liver disease: the mist gradually clears. J Hepatol 2008 48 (suppl 1) S104-S112
    • (2008) J Hepatol , vol.48 , Issue.SUPPL 1
    • De Alwis, N.M.1    Day, C.P.2
  • 49
    • 67649170396 scopus 로고    scopus 로고
    • Nonalcoholic fatty liver disease as a contributor to hypercoagulation and thrombophilia in the metabolic syndrome
    • Targher G, Chonchol M, Miele L, Zoppini G, Pichiri I, Muggeo M. Nonalcoholic fatty liver disease as a contributor to hypercoagulation and thrombophilia in the metabolic syndrome. Semin Thromb Hemost 2009 35 (3) 277-287
    • (2009) Semin Thromb Hemost , vol.35 , Issue.3 , pp. 277-287
    • Targher, G.1    Chonchol, M.2    Miele, L.3    Zoppini, G.4    Pichiri, I.5    Muggeo, M.6
  • 50
    • 34547596738 scopus 로고    scopus 로고
    • High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH
    • Yoneda M, Mawatari H, Fujita K et al. High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH. J Gastroenterol 2007 42 (7) 573-582
    • (2007) J Gastroenterol , vol.42 , Issue.7 , pp. 573-582
    • Yoneda, M.1    Mawatari, H.2    Fujita, K.3
  • 51
    • 44949233003 scopus 로고    scopus 로고
    • Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis
    • Wieckowska A, Papouchado B G., Li Z, Lopez R, Zein N N., Feldstein A E. Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis. Am J Gastroenterol 2008 103 (6) 1372-1379
    • (2008) Am J Gastroenterol , vol.103 , Issue.6 , pp. 1372-1379
    • Wieckowska, A.1    Papouchado, B.G.2    Li, Z.3    Lopez, R.4    Zein, N.N.5    Feldstein, A.E.6
  • 52
    • 49449083979 scopus 로고    scopus 로고
    • Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake
    • Thuy S, Ladurner R, Volynets V et al. Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake. J Nutr 2008 138 (8) 1452-1455
    • (2008) J Nutr , vol.138 , Issue.8 , pp. 1452-1455
    • Thuy, S.1    Ladurner, R.2    Volynets, V.3
  • 53
    • 44449109670 scopus 로고    scopus 로고
    • NASH predicts plasma inflammatory biomarkers independently of visceral fat in men
    • Targher G, Bertolini L, Rodella S et al. NASH predicts plasma inflammatory biomarkers independently of visceral fat in men. Obesity (Silver Spring) 2008 16 (6) 1394-1399
    • (2008) Obesity (Silver Spring) , vol.16 , Issue.6 , pp. 1394-1399
    • Targher, G.1    Bertolini, L.2    Rodella, S.3
  • 55
    • 35748972366 scopus 로고    scopus 로고
    • Genes involved in fatty acid partitioning and binding, lipolysis, monocyte/macrophage recruitment, and inflammation are overexpressed in the human fatty liver of insulin-resistant subjects
    • Westerbacka J, Kolak M, Kiviluoto T et al. Genes involved in fatty acid partitioning and binding, lipolysis, monocyte/macrophage recruitment, and inflammation are overexpressed in the human fatty liver of insulin-resistant subjects. Diabetes 2007 56 (11) 2759-2765
    • (2007) Diabetes , vol.56 , Issue.11 , pp. 2759-2765
    • Westerbacka, J.1    Kolak, M.2    Kiviluoto, T.3
  • 56
    • 34247853485 scopus 로고    scopus 로고
    • The adipocyte as an active participant in energy balance and metabolism
    • Badman M K., Flier J S. The adipocyte as an active participant in energy balance and metabolism. Gastroenterology 2007 132 (6) 2103-2115
    • (2007) Gastroenterology , vol.132 , Issue.6 , pp. 2103-2115
    • Badman, M.K.1    Flier, J.S.2
  • 57
    • 34247857663 scopus 로고    scopus 로고
    • Obesity, inflammation, and insulin resistance
    • Shoelson S E., Herrero L, Naaz A. Obesity, inflammation, and insulin resistance. Gastroenterology 2007 132 (6) 2169-2180
    • (2007) Gastroenterology , vol.132 , Issue.6 , pp. 2169-2180
    • Shoelson, S.E.1    Herrero, L.2    Naaz, A.3
  • 59
    • 34047155003 scopus 로고    scopus 로고
    • Visceral fat adipokine secretion is associated with systemic inflammation in obese humans
    • DOI 10.2337/db06-1656
    • Fontana L, Eagon J C., Trujillo M E., Scherer P E., Klein S. Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes 2007 56 (4) 1010-1013 (Pubitemid 46525079)
    • (2007) Diabetes , vol.56 , Issue.4 , pp. 1010-1013
    • Fontana, L.1    Eagon, J.C.2    Trujillo, M.E.3    Scherer, P.E.4    Klein, S.5
  • 63
    • 0034676629 scopus 로고    scopus 로고
    • Cytokines in alcoholic and nonalcoholic steatohepatitis
    • Tilg H, Diehl A M. Cytokines in alcoholic and nonalcoholic steatohepatitis. N Engl J Med 2000 343 (20) 1467-1476
    • (2000) N Engl J Med , vol.343 , Issue.20 , pp. 1467-1476
    • Tilg, H.1    Diehl, A.M.2
  • 65
    • 53549112749 scopus 로고    scopus 로고
    • Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: Causal effect or epiphenomenon?
    • Targher G, Marra F, Marchesini G. Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon? Diabetologia 2008 51 (11) 1947-1953
    • (2008) Diabetologia , vol.51 , Issue.11 , pp. 1947-1953
    • Targher, G.1    Marra, F.2    Marchesini, G.3
  • 67
    • 0037962069 scopus 로고    scopus 로고
    • Plasma PAI-1 levels are more strongly related to liver steatosis than to adipose tissue accumulation
    • Alessi M C., Bastelica D, Mavri A et al. Plasma PAI-1 levels are more strongly related to liver steatosis than to adipose tissue accumulation. Arterioscler Thromb Vasc Biol 2003 23 (7) 1262-1268
    • (2003) Arterioscler Thromb Vasc Biol , vol.23 , Issue.7 , pp. 1262-1268
    • Alessi, M.C.1    Bastelica, D.2    Mavri, A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.